What This Report Will Provide?

This study involved four major activities in estimating the current size of the neuroendoscopy market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Expected Revenue Growth:

The neuroendoscopy market is expected to reach USD 218.9 million by 2022 from USD 163.9 million in 2016, at a CAGR of 5.1%

Major Growth Boosters:

Factors such as favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery are driving the growth of this market. However, the high cost of neuroendoscopy procedures and equipment may hinder the growth of the market.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68126508

Recent Developments:

In 2017, KARL STORZ partnered with Ortega Clinic (Peru) to equip the hospital with an integrated KARL STORZ 3D operating room (OR) and accessories

In 2017, B.Braun opened a subsidiary in Zambia. This will help the company to establish its business in Zambia and expand its presence in the African region.

Regional Growth Analysis:

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The dominance of the North American market is attributed to factors such as favorable government initiatives, rising prevalence of neurological disorders, increasing investments by hospitals to purchase new neuroendoscopy equipment, and increasing research activities.

Future growth opportunities are going to be dependent on growing healthcare market in emerging economies such as Brazil, Russia, India, China, and South Africa (BRICS), as they are among the fastest-growing economies in the world. The World Economic Forum has estimated that these emerging economies will account for around one-third of the global healthcare expenditure.

Key Questions Addressed in The Report:

1. Who are the top 10 players operating in the global neuroendoscopy market?
2. What are the drivers, restraints, opportunities, and challenges in the neuroendoscopy Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of neuroendoscopy in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=68126508

Transcranial neuroendoscopy is used in the diagnosis and treatment of larger tumors with significant suprasellar extension. There are two types of endoscopic transcranial approaches transglabellar or supraorbital which are widely used by neurosurgeons. The transcranial approach is more invasive as compared to the transnasal neuroendoscopic approach. However, in order to reduce trauma, this procedure is used in conjunction with transnasal neuroendoscopy.

Key Players:

KARL STORZ (Germany), B. Braun (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hangzhou Hawk Optical Electronic Instruments (China), Machida Endoscope (Japan), Tonglu Wanhe Medical Instrument (China), Schindler Endoskopie (Germany), Clarus Medical (US), LocaMed (UK), and Visionsense Corporation (US) are the key players operating in this market.